{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:46:20Z","timestamp":1760147180154,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T00:00:00Z","timestamp":1673740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008546","name":"Swedish Diabetes Foundation","doi-asserted-by":"publisher","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}],"id":[{"id":"10.13039\/501100008546","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AstraZeneca R&amp;D, the Exodiab\u2014Excellence of Diabetes Research in Sweden","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]},{"name":"Ernfors Foundation","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]},{"name":"the Agnes and Mac Rudberg Foundation","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]},{"name":"Swedish Society for Medical Research","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]},{"name":"P.O. Zetterling Foundation","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]},{"name":"Novo Nordisk Foundation","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]},{"name":"European Commission via the Marie Sklodowska Curie Innovative Training Network TREATMENT","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]},{"name":"Uppsala University Hospital ALF grants","award":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"],"award-info":[{"award-number":["DIA2021-661","NNF20OC0063864","H2020-MSCA-ITN-721236"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Metabolic inflexibility is a hallmark of insulin resistance and can be extensively explored with high-throughput metabolomics techniques. However, the dynamic regulation of the metabolome during an oral glucose tolerance test (OGTT) in subjects with type 2 diabetes (T2D) is largely unknown. We aimed to identify alterations in metabolite responses to OGTT in subjects with T2D using untargeted metabolomics of both plasma and subcutaneous adipose tissue (SAT) samples. Twenty subjects with T2D and twenty healthy controls matched for sex, age, and body mass index (BMI) were profiled with untargeted metabolomics both in plasma (755 metabolites) and in the SAT (588) during an OGTT. We assessed metabolite concentration changes 90 min after the glucose load, and those responses were compared between patients with T2D and controls. Post-hoc analyses were performed to explore the associations between glucose-induced metabolite responses and markers of obesity and glucose metabolism, sex, and age. During the OGTT, T2D subjects had an impaired reduction in plasma levels of several metabolite families, including acylcarnitines, amino acids, acyl ethanolamines, and fatty acid derivates (p &lt; 0.05), compared to controls. Additionally, patients with T2D had a greater increase in plasma glucose and fructose levels during the OGTT compared to controls (p &lt; 0.05). The plasma concentration change of most metabolites after the glucose load was mainly associated with indices of hyperglycemia rather than insulin resistance, insulin secretion, or BMI. In multiple linear regression analyses, hyperglycemia indices (glucose area under the curve (AUC) during OGTT and glycosylated hemoglobin (HbA1c)) were the strongest predictors of plasma metabolite changes during the OGTT. No differences were found in the adipose tissue metabolome in response to the glucose challenge between T2D and controls. Using a metabolomics approach, we show that T2D patients display attenuated responses in several circulating metabolite families during an OGTT. Besides the well-known increase in monosaccharides, the glucose-induced lowering of amino acids, acylcarnitines, and fatty acid derivatives was attenuated in T2D subjects compared to controls. These data support the hypothesis of inflexibility in several metabolic pathways, which may contribute to dysregulated substrate partitioning and turnover in T2D. These findings are not directly associated with changes in adipose tissue metabolism; therefore, other tissues, such as muscle and liver, are probably of greater importance.<\/jats:p>","DOI":"10.3390\/metabo13010131","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T01:31:15Z","timestamp":1673832675000},"page":"131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7920-8909","authenticated-orcid":false,"given":"Giovanni","family":"Fanni","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, 751 85 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2639-9481","authenticated-orcid":false,"given":"Jan W.","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, 751 85 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-3899","authenticated-orcid":false,"given":"Maria J.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, 751 85 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/dme.14464","article-title":"Diabetes Is Not (Only) a Disorder of Glucose Metabolism!","volume":"38","author":"Fanni","year":"2021","journal-title":"Diabet. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","article-title":"Metabolic Flexibility in Health and Disease","volume":"25","author":"Goodpaster","year":"2017","journal-title":"Cell Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12263-018-0609-3","article-title":"Exploring the Cellular Network of Metabolic Flexibility in the Adipose Tissue","volume":"13","author":"Tareen","year":"2018","journal-title":"Genes Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1113\/JP273282","article-title":"Sedentary Behaviour Is a Key Determinant of Metabolic Inflexibility","volume":"596","author":"Rynders","year":"2018","journal-title":"J. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1210\/jendso\/bvaa127","article-title":"Metabolomic Profiling After a Meal Shows Greater Changes and Lower Metabolic Flexibility in Cardiometabolic Diseases","volume":"4","author":"Yu","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","article-title":"Circulating Metabolites and the Risk of Type 2 Diabetes: A Prospective Study of 11,896 Young Adults from Four Finnish Cohorts","volume":"62","author":"Mustelin","year":"2019","journal-title":"Diabetologia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103799","DOI":"10.1016\/j.ebiom.2021.103799","article-title":"Changes in Metabolomics Profiles over Ten Years and Subsequent Risk of Developing Type 2 Diabetes: Results from the Nurses\u2019 Health Study","volume":"75","author":"Wittenbecher","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and Metabolic Diseases: Where Do We Stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1210\/jc.2019-01104","article-title":"Plasma Metabolomics to Identify and Stratify Patients with Impaired Glucose Tolerance","volume":"104","author":"Wildberg","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/dc15-2251","article-title":"Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis","volume":"39","author":"Hruby","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach","volume":"62","author":"Menni","year":"2013","journal-title":"Diabetes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite Profiles and the Risk of Developing Diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI1326","article-title":"Bidirectional Modulation of Insulin Action by Amino Acids","volume":"101","author":"Patti","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1152\/ajpendo.90748.2008","article-title":"Changes of the Plasma Metabolome during an Oral Glucose Tolerance Test: Is There More than Glucose to Look At?","volume":"296","author":"Zhao","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2337\/db12-0754","article-title":"Metabolite Profiles During Oral Glucose Challenge","volume":"62","author":"Ho","year":"2013","journal-title":"Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/msb.2008.50","article-title":"Metabolic Profiling of the Human Response to a Glucose Challenge Reveals Distinct Axes of Insulin Sensitivity","volume":"4","author":"Shaham","year":"2008","journal-title":"Mol. Syst. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Huo, S., Sun, L., Zong, G., Shen, X., Zheng, H., Jin, Q., Li, H., Yin, H., and Lin, X. (2021). Changes in Plasma Metabolome Profiles Following Oral Glucose Challenge among Adult Chinese. Nutrients, 13.","DOI":"10.3390\/nu13051474"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.metabol.2016.09.008","article-title":"Impaired Adipose Tissue Lipid Storage, but Not Altered Lipolysis, Contributes to Elevated Levels of NEFA in Type 2 Diabetes. Degree of Hyperglycemia and Adiposity Are Important Factors","volume":"65","author":"Pereira","year":"2016","journal-title":"Metabolism"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41598-017-19120-0","article-title":"Missing Value Imputation Approach for Mass Spectrometry-Based Metabolomics Data","volume":"8","author":"Wei","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9653","DOI":"10.1038\/s41598-019-45906-5","article-title":"Intra- and Inter-Individual Metabolic Profiling Highlights Carnitine and Lysophosphatidylcholine Pathways as Key Molecular Defects in Type 2 Diabetes","volume":"9","author":"Diamanti","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1038\/s41598-018-26701-0","article-title":"Glucose Challenge Metabolomics Implicates Medium-Chain Acylcarnitines in Insulin Resistance","volume":"8","author":"Nowak","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2015.01.014","article-title":"Targeted Metabolomic Analysis Reveals the Association between the Postprandial Change in Palmitic Acid, Branched-Chain Amino Acids and Insulin Resistance in Young Obese Subjects","volume":"108","author":"Liu","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1530\/EJE-20-1359","article-title":"Tissue-Specific Glucose Partitioning and Fat Content in Prediabetes and Type 2 Diabetes: Whole-Body PET\/MRI during Hyperinsulinemia","volume":"184","author":"Eriksson","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2337\/db08-0043","article-title":"Metabolic Flexibility in Response to Glucose Is Not Impaired in People with Type 2 Diabetes after Controlling for Glucose Disposal Rate","volume":"57","author":"Galgani","year":"2008","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kim, H.W. (2021). Metabolomic Approaches to Investigate the Effect of Metformin: An Overview. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910275"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical Pharmacokinetics of Metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fendo.2020.00617","article-title":"Coordinated Modulation of Energy Metabolism and Inflammation by Branched-Chain Amino Acids and Fatty Acids","volume":"11","author":"Ye","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yoon, M.-S. (2016). The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism. Nutrients, 8.","DOI":"10.3390\/nu8070405"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00125-021-05481-9","article-title":"Branched-Chain Amino Acid Metabolism Is Regulated by ERR\u03b1 in Primary Human Myotubes and Is Further Impaired by Glucose Loading in Type 2 Diabetes","volume":"64","author":"Chibalin","year":"2021","journal-title":"Diabetologia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between Lipids and Branched-Chain Amino Acids in Development of Insulin Resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-Chain Amino Acids in Metabolic Signalling and Insulin Resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41387-022-00213-3","article-title":"Role of Branched-Chain Amino Acid Metabolism in the Pathogenesis of Obesity and Type 2 Diabetes-Related Metabolic Disturbances BCAA Metabolism in Type 2 Diabetes","volume":"12","author":"Vanweert","year":"2022","journal-title":"Nutr. Diabetes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/oby.20868","article-title":"Metabolite Profile Deviations in an Oral Glucose Tolerance Test-a Comparison between Lean and Obese Individuals","volume":"22","author":"Geidenstam","year":"2014","journal-title":"Obesity"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, Q., Jokelainen, J., Auvinen, J., Puukka, K., Kein\u00e4nen-Kiukaanniemi, S., J\u00e4rvelin, M.R., Kettunen, J., M\u00e4kinen, V.P., and Ala-Korpela, M. (2019). Insulin Resistance and Systemic Metabolic Changes in Oral Glucose Tolerance Test in 5340 Individuals: An Interventional Study. BMC Med., 17.","DOI":"10.1186\/s12916-019-1440-4"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1210\/clinem\/dgz240","article-title":"Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis","volume":"105","author":"Sun","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Arneth, B., Arneth, R., and Shams, M. (2019). Metabolomics of Type 1 and Type 2 Diabetes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102467"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as Regulators of Insulin Sensitivity and Metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.diabres.2018.03.045","article-title":"Metabolite Changes in Risk of Type 2 Diabetes Mellitus in Cohort Studies: A Systematic Review and Meta-Analysis","volume":"140","author":"Park","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clinbiochem.2020.03.007","article-title":"Discovery and Comparison of Serum Biomarkers for Diabetes Mellitus and Metabolic Syndrome Based on UPLC-Q-TOF\/MS","volume":"82","author":"Liu","year":"2020","journal-title":"Clin. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E463","DOI":"10.1210\/jc.2014-2357","article-title":"Metabolomic Profile Associated with Insulin Resistance and Conversion to Diabetes in the Insulin Resistance Atherosclerosis Study","volume":"100","author":"Palmer","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/ije\/dyw221","article-title":"Plasma Metabolomics Identified Novel Metabolites Associated with Risk of Type 2 Diabetes in Two Prospective Cohorts of Chinese Adults","volume":"45","author":"Qiu","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1038\/s41598-021-85684-7","article-title":"Triangulating Evidence from Longitudinal and Mendelian Randomization Studies of Metabolomic Biomarkers for Type 2 Diabetes","volume":"11","author":"Porcu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1093\/jn\/nxaa273","article-title":"High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevenci\u00f3n Con Dieta Mediterr\u00e1nea (PREDIMED) Study","volume":"150","author":"Papandreou","year":"2020","journal-title":"J. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"McCann, M.R., de la Rosa, M.V.G., Rosania, G.R., and Stringer, K.A. (2021). L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine. Metabolites, 11.","DOI":"10.3390\/metabo11010051"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fendo.2019.00870","article-title":"Decreases in Circulating Concentrations of Long-Chain Acylcarnitines and Free Fatty Acids During the Glucose Tolerance Test Represent Tissue-Specific Insulin Sensitivity","volume":"10","author":"Makarova","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/jdi.12622","article-title":"Plasma Mannose Level, a Putative Indicator of Glycogenolysis, and Glucose Tolerance in Japanese Individuals","volume":"8","author":"Yoshimura","year":"2017","journal-title":"J. Diabetes Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E534","DOI":"10.1152\/ajpendo.00451.2004","article-title":"Hepatic Glycogen Breakdown Is Implicated in the Maintenance of Plasma Mannose Concentration","volume":"288","author":"Taguchi","year":"2005","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.me.26.020175.002513","article-title":"Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus","volume":"26","author":"Gabbay","year":"1975","journal-title":"Annu. Rev. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/ncomms3434","article-title":"Endogenous Fructose Production and Metabolism in the Liver Contributes to the Development of Metabolic Syndrome","volume":"4","author":"Lanaspa","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2337\/diab.28.11.957","article-title":"Insulin Inhibition of Lipolysis of Human Adipocytes the Role of Cyclic Adenosine Monophosphate","volume":"28","author":"Burns","year":"1979","journal-title":"Diabetes"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1017\/S0007114500002105","article-title":"Insulin Response and Changes in Composition of Non-Esterified Fatty Acids in Blood Plasma of Middle-Aged Men Following Isoenergetic Fatty and Carbohydrate Breakfasts","volume":"84","author":"Frape","year":"2000","journal-title":"Br. J. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2337\/diab.16.3.175","article-title":"Changes of Individual Free Fatty Acids during Glucose Tolerance Test","volume":"16","author":"Nakamura","year":"1967","journal-title":"Diabetes"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01219669","article-title":"The Effect of a Glucose Load on Plasma Fatty Acids and Lipolysis in Adipose Tissue of Obese Diabetic and Non-Diabetic Patients","volume":"10","author":"Gilbert","year":"1974","journal-title":"Diabetologia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-nutr-043020-090216","article-title":"Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective","volume":"41","author":"Rahman","year":"2021","journal-title":"Annu. Rev. Nutr."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Chiazza, F., and Collino, M. (2016). Peroxisome Proliferator-Activated Receptors (PPARs) in Glucose Control. Molecular Nutrition and Diabetes: A Volume in the Molecular Nutrition Series, Academic Press.","DOI":"10.1016\/B978-0-12-801585-8.00009-9"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100763","DOI":"10.1016\/j.xcrm.2022.100763","article-title":"Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues","volume":"3","author":"Diamanti","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diabetes.50.7.1612","article-title":"Effects of Acute Changes of Plasma Free Fatty Acids on Intramyocellular Fat Content and Insulin Resistance in Healthy Subjects","volume":"50","author":"Boden","year":"2001","journal-title":"Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2014.11.034","article-title":"Metabolic Inflexibility: When Mitochondrial Indecision Leads to Metabolic Gridlock","volume":"159","author":"Muoio","year":"2014","journal-title":"Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E1175","DOI":"10.1152\/ajpendo.00630.2012","article-title":"Regulation of Adipose Branched-Chain Amino Acid Catabolism Enzyme Expression and Cross-Adipose Amino Acid Flux in Human Obesity","volume":"304","author":"Lackey","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/1\/131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:36Z","timestamp":1760119596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/1\/131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["metabo13010131"],"URL":"https:\/\/doi.org\/10.3390\/metabo13010131","relation":{},"ISSN":["2218-1989"],"issn-type":[{"type":"electronic","value":"2218-1989"}],"subject":[],"published":{"date-parts":[[2023,1,15]]}}}